Answers are grounded in this paper and cite their sources.
Background: Interleukin1β (IL-1β) increases during inflammation and functions as a mediator that terminates endothelial dysfunction and regulates cellular apoptosis in preeclampsia. Parecoxib is a potential agent because of its superiority as an analgesic and anti-inflammatory that can work peripherally and centrally, with minimal side effects on the mother and baby.Objective: This study aimed to determine the relationship between IL-1β levels and visual analog scale (VAS) scores in preeclampsia patients who received parecoxib perioperatively for cesarean section with spinal anesthesia.Methods: Non-experimental cross-sectional research on preeclampsia patients who received perioperative parecoxib and underwent cesarean section with spinal anesthesia as many as 18 people at Arifin Ahmad Hospital, Riau Province, and Bina Kasih Hospital, Pekanbaru. Samples were taken by Consecutive Sampling.Result: There was a moderate negative correlation between IL-1β and VAS (p <0.05; correlation coefficient -0.487).Conclusion: In preeclampsia patients who received parecoxib following a 24-hour spinal anesthetic cesarean surgery, there is a correlation between IL-1β levels and VAS scores.
No takes yet. Share an insight, caveat, or question.
Irawan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: